Cairo - Mubasher: Memphis Pharmaceutical and Chemical Industries posted net profits of EGP 247,400 in the first quarter of the fiscal year 2015/16, down from EGP 6 million a year before.
Earlier, the company released its adjusted financial statements for the fiscal year 2014/15, which reflected losses of EGP 10.3 million against profits of EGP 14,000 at the previous year.
The firm is capitalized at EGP 56.3 million, distributed across 5.6 million shares at EGP 10 par value each.
